• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水肿诱导的 131Cs 前列腺永久植入近距离放疗患者肿瘤存活分数和肿瘤控制概率的变化。

Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients.

机构信息

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, PA 15232, USA.

出版信息

J Appl Clin Med Phys. 2013 Jan 7;14(1):3862. doi: 10.1120/jacmp.v14i1.3862.

DOI:10.1120/jacmp.v14i1.3862
PMID:23318378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5713662/
Abstract

The study is designed to investigate the effect of edema on the delivered dose, tumor cell surviving fraction (SF), and tumor control probability (TCP) in the patients of prostate cancer who underwent (131)Cs permanent seed implantation. The dose reduction, the SF, and the TCP for edematous prostate implants were calculated for 31 patients who underwent real-time (131)Cs permanent seed implantation for edema half-lives (EHL), ranging from 4 days to 34 days and for edema magnitudes (M0) varying from 5% to 60% of the actual prostate volume. A dose reduction in (131)Cs implants varied from 1.1% (for EHL = 4 days and M(0) = 5%) to 32.3% (for EHL = 34 days and M(0) = 60%). These are higher than the dose reduction in 125I implants, which vary from 0.3% (for EHL = 4 days and M(0) = 5%) to 17.5% (for EHL = 34 days and M(0) = 60%). As EHL increased from 4 days to 34 days and edema magnitude increased from 5% to 60%, the natural logarithmic value of SF increased by 4.57 and the TCP decreased by 0.80. Edema induced increase in the SF and decrease in the TCP in (131)Cs seed implants, is significantly more pronounced in a combination of higher edema magnitude and larger edema half-lives than for less edema magnitude and lower edema half-lives, as compared for M(0) = 60% and EHL = 34, and M(0) = 5% and EHL = 4 days.

摘要

本研究旨在探讨前列腺癌患者接受(131)Cs 永久性种子植入术后水肿对放射性剂量、肿瘤细胞存活分数(SF)和肿瘤控制概率(TCP)的影响。对于接受实时(131)Cs 永久性种子植入术的 31 例水肿半衰期(EHL)为 4 天至 34 天、水肿幅度(M0)为实际前列腺体积的 5%至 60%的患者,计算了放射性剂量减少、SF 和 TCP。(131)Cs 植入物的放射性剂量减少幅度从 EHL = 4 天和 M0 = 5%时的 1.1%(1.1%)到 EHL = 34 天和 M0 = 60%时的 32.3%。这些剂量减少幅度高于 125I 植入物的剂量减少幅度,从 EHL = 4 天和 M0 = 5%时的 0.3%(0.3%)到 EHL = 34 天和 M0 = 60%时的 17.5%。随着 EHL 从 4 天增加到 34 天,水肿幅度从 5%增加到 60%,SF 的自然对数增加了 4.57,TCP 减少了 0.80。与水肿幅度和水肿半衰期较小的情况相比,(131)Cs 种子植入物中水肿引起的 SF 增加和 TCP 降低在较高的水肿幅度和较大的水肿半衰期组合中更为显著,与 M0 = 60%和 EHL = 34 相比,以及 M0 = 5%和 EHL = 4 天。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/5ede5fe1a2a5/ACM2-14-031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/888ce5d26c79/ACM2-14-031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/a03633c6a730/ACM2-14-031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/5ede5fe1a2a5/ACM2-14-031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/888ce5d26c79/ACM2-14-031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/a03633c6a730/ACM2-14-031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/5713662/5ede5fe1a2a5/ACM2-14-031-g003.jpg

相似文献

1
Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients.水肿诱导的 131Cs 前列腺永久植入近距离放疗患者肿瘤存活分数和肿瘤控制概率的变化。
J Appl Clin Med Phys. 2013 Jan 7;14(1):3862. doi: 10.1120/jacmp.v14i1.3862.
2
SU-E-T-07: Edema Induced Changes in Tumor Cell Survival Fraction and Tumor Control Probability in 131Cs Permanent Prostate Implant Patients.SU-E-T-07:131铯永久性前列腺植入患者中水肿引起的肿瘤细胞存活分数和肿瘤控制概率的变化
Med Phys. 2012 Jun;39(6Part9):3703. doi: 10.1118/1.4735061.
3
Prescription dose in permanent (131)Cs seed prostate implants.永久性(131)铯籽源前列腺植入的处方剂量。
Med Phys. 2005 Aug;32(8):2496-502. doi: 10.1118/1.1951062.
4
Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.125I和103Pd前列腺永久性种子植入中水肿诱导肿瘤细胞存活率增加——一种生物数学模型
Phys Med Biol. 2002 Apr 7;47(7):1185-204. doi: 10.1088/0031-9155/47/7/313.
5
Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.前列腺水肿对使用新型¹³¹Cs(CS - 1型)种子进行永久性粒子植入剂量测定的潜在影响。
Med Phys. 2006 Apr;33(4):968-75. doi: 10.1118/1.2179170.
6
Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.131Cs前列腺永久性粒子植入相关水肿对剂量学质量指标的影响。
Med Phys. 2009 Aug;36(8):3536-42. doi: 10.1118/1.3160553.
7
Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.¹²⁵I和¹⁰³Pd前列腺籽源植入基于图像的剂量评估的最佳时机
Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):1063-72. doi: 10.1016/s0360-3016(99)00282-5.
8
Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.水肿、相对生物效应和剂量异质性对前列腺近距离治疗的影响。
Med Phys. 2006 Apr;33(4):1025-32. doi: 10.1118/1.2181294.
9
Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.前列腺水肿对 131Cs 永久性前列腺种子植入的影响:一项剂量学和放射生物学研究。
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):621-7. doi: 10.1016/j.ijrobp.2010.07.001. Epub 2010 Oct 6.
10
Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.永久性粒子植入中为实现最佳前列腺剂量覆盖的同位素半衰期与前列腺水肿之间的关系。
Med Phys. 2008 May;35(5):1970-7. doi: 10.1118/1.2900722.

本文引用的文献

1
Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.前列腺水肿对 131Cs 永久性前列腺种子植入的影响:一项剂量学和放射生物学研究。
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):621-7. doi: 10.1016/j.ijrobp.2010.07.001. Epub 2010 Oct 6.
2
Use of Cesium-131 radioactive seeds in prostate permanent implants.铯 - 131放射性种子源在前列腺永久性植入中的应用。
J Med Phys. 2009 Oct;34(4):191-3. doi: 10.4103/0971-6203.56077.
3
AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.
AAPM 关于前列腺癌永久性间质近距离放射治疗剂量处方和报告方法的建议:第 137 任务组报告。
Med Phys. 2009 Nov;36(11):5310-22. doi: 10.1118/1.3246613.
4
Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.131Cs前列腺永久性粒子植入相关水肿对剂量学质量指标的影响。
Med Phys. 2009 Aug;36(8):3536-42. doi: 10.1118/1.3160553.
5
Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.铯-131永久性前列腺近距离治疗的推荐意见:铯咨询小组的共识报告
Brachytherapy. 2008 Oct-Dec;7(4):290-6. doi: 10.1016/j.brachy.2008.05.004. Epub 2008 Sep 7.
6
Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.使用¹³¹Cs和¹²⁵I进行前列腺永久性植入近距离放射治疗时前列腺和尿道的剂量学及生物有效剂量参数比较
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):247-54. doi: 10.1016/j.ijrobp.2008.05.013.
7
Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.基于针后体积并进行早期剂量学评估的计划对铯-131永久性前列腺籽源植入有益。
Brachytherapy. 2008 Jul-Sep;7(3):237-41. doi: 10.1016/j.brachy.2008.04.003. Epub 2008 Jul 2.
8
Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.永久性粒子植入中为实现最佳前列腺剂量覆盖的同位素半衰期与前列腺水肿之间的关系。
Med Phys. 2008 May;35(5):1970-7. doi: 10.1118/1.2900722.
9
On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.关于在预先计划的铯-131前列腺近距离放射治疗中补偿水肿引起的剂量减少的必要性。
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):303-10. doi: 10.1016/j.ijrobp.2007.09.007. Epub 2007 Nov 5.
10
Brachytherapy dosimetry parameters calculated for a 131Cs source.为¹³¹铯源计算的近距离治疗剂量测定参数。
Med Phys. 2007 Feb;34(2):754-62. doi: 10.1118/1.2432162.